Background

The International Trade Commission has recently announced the following actions in intellectual property rights infringement investigations.

For more information on pursuing or mitigating IPR-related import restrictions, please contact customs and trade attorney Lee Sandler at (305) 894-1000.

Bag-in-container devices – termination without the imposition of import restrictions of patent infringement investigation 337-TA-1115 of blow-molded bag-in-container devices, associated components, and end products containing or using same based on Anheuser-Busch InBev S.A.’s withdrawal of its complaint

Fuel vapor canisters – March 2 deadline for written submissions on public interest issues raised by a recommendation in investigation 337-TA-1140 of multi-stage fuel vapor canister systems and activated carbon components thereof to issue a limited exclusion order and cease and desist order if a violation is found

LED products – termination of patent infringement investigation 337-TA-1165 of light-emitting diode products, systems, and components thereof with respect to one patent claim withdrawn by complainants Lighting Science Group Corporation, Health Inc., and Global Value Lighting LLC

Memory modules – final initial determination of patent infringement in investigation 337-TA-1089 of memory modules and components thereof and Feb. 14 deadline for comments on the form of remedy, if any, that should be ordered; the effect of any such remedy on the public interest; and the amount of the bond under which infringing articles could continue to enter the U.S. during the 60-day period the president has to review any ITC-ordered remedy

Oligosaccharides – final initial determination of patent infringement in investigation 337-TA-1120 of human milk oligosaccharides and methods of producing same and request for written submissions by Feb. 18 on the form of remedy, if any, that should be ordered; the effect of any such remedy on the public interest; and the amount of the bond under which infringing articles could continue to enter the U.S. during the 60-day period for presidential review of any ITC-ordered remedy

Close

Cookie Consent

We use cookies on our website. By continuing to use our website, you agree to the Privacy Policy and Terms of Use.